Skip to Content

Proposed Rule

Zentox Corporation; Withdrawal of Food Additive Petition

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice of withdrawal.

SUMMARY:

The Food and Drug Administration (FDA or we) is announcing the withdrawal, without prejudice to a future filing, of a food additive petition (FAP 8A4775) proposing that the food additive regulations be amended to provide for the safe use of monochloramine as an antimicrobial agent in poultry process chiller water.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Judith Kidwell, Center for Food Safety and Applied Nutrition (HFS-265), Food and Drug Administration, 5100 Paint Start Printed Page 28164Branch Pkwy., College Park, MD 20740-3835, 240-402-1071.

End Further Info

DATES:

May 14, 2013.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In a notice published in the Federal Register of September 3, 2008 (73 FR 51490), we announced that Zentox Corp., c/o Burdock Group, 801 North Orange Ave., suite 710, Orlando, FL 32801, had filed a food additive petition (FAP 8A4775). The petition proposed to amend the food additive regulations in part 173—Secondary Direct Food Additives Permitted in Food for Human Consumption (21 CFR part 173) to provide for the safe use of monochloramine as an antimicrobial agent in poultry process chiller water. Zentox Corp. has now withdrawn the petition without prejudice to a future filing (21 CFR 171.7).

Start Signature

Dated: May 9, 2013.

Dennis M. Keefe,

Director, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition.

End Signature End Supplemental Information

[FR Doc. 2013-11499 Filed 5-13-13; 8:45 am]

BILLING CODE 4160-01-P